Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiana Lucà

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Discover Oncology|November 17, 2025
SGLT2 inhibitors and their role in reducing mortality among cancer patients with type 2 diabetes undergoing immune checkpoint inhibitor therapyFabiana Lucà, Iris Parrini
Journal of Clinical Medicine|March 17, 2025
The Elderly Patient with Atrial Fibrillation: Optimal Treatment StrategiesFabiana Lucà, Iris Parrini
Journal of Clinical Medicine|July 29, 2025
The Multidisciplinary Approach to GLP-1 RA and SGLT2 Inhibitors in Cardiometabolic Care: A New Era for Patients with Diabetes and Heart DiseaseFabiana Lucà, Maurizio Giuseppe Abrignani
Reviews in Cardiovascular Medicine|January 12, 2026
Spontaneous Coronary Artery Dissection in WomenFabiana Lucà, Iris Parrini, Alaide Chieffo
Pacing and Clinical Electrophysiology : PACE|May 9, 2009
Late sensing due to extremely delayed right ventricular activation in arrhythmogenic right ventricular cardiomyopathyOreste Bramanti, Concetta Melluso, Fabiana Lucà, et al.
World Journal of Cardiology|October 3, 2014
Systemic venous atrium stimulation in transvenous pacing after mustard procedureCalogero Puntrello, Fabiana Lucà, Gaspare Rubino, et al.
Journal of Clinical Medicine|June 10, 2022
Reply to Kielb et al. Untapped Potential for Female Patients? Comment on "Lucà et al. Update on Management of Cardiovascular Diseases in Women. <i>J. Clin. Med.</i> 2022, <i>11</i>, 1176"Fabiana Lucà, Furio Colivicchi, Roberta Rossini, et al.
The American Journal of Cardiology|June 24, 2026
Semaglutide for the Silent Phenotype: A Translational Signal in Obesity-Driven HFpEFRoberto Ceravolo, Fabiana Lucà, Michele Massimo Gulizia, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 6, 2019
Emerging clinical setting of direct oral anticoagulants: atherothrombotic events preventionStefania A Di Fusco, Fabiana Lucà, Michele M Gulizia, et al.
World Journal of Cardiology|June 20, 2014
Unreliability of aortic size index to predict risk of aortic dissection in a patient with Turner syndromeJan Nijs, Sandro Gelsomino, Fabiana Lucà, et al.
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Discover Oncology|November 17, 2025
SGLT2 inhibitors and their role in reducing mortality among cancer patients with type 2 diabetes undergoing immune checkpoint inhibitor therapyFabiana Lucà, Iris Parrini
Journal of Clinical Medicine|March 17, 2025
The Elderly Patient with Atrial Fibrillation: Optimal Treatment StrategiesFabiana Lucà, Iris Parrini
Journal of Clinical Medicine|July 29, 2025
The Multidisciplinary Approach to GLP-1 RA and SGLT2 Inhibitors in Cardiometabolic Care: A New Era for Patients with Diabetes and Heart DiseaseFabiana Lucà, Maurizio Giuseppe Abrignani
Reviews in Cardiovascular Medicine|January 12, 2026
Spontaneous Coronary Artery Dissection in WomenFabiana Lucà, Iris Parrini, Alaide Chieffo
Pacing and Clinical Electrophysiology : PACE|May 9, 2009
Late sensing due to extremely delayed right ventricular activation in arrhythmogenic right ventricular cardiomyopathyOreste Bramanti, Concetta Melluso, Fabiana Lucà, et al.
World Journal of Cardiology|October 3, 2014
Systemic venous atrium stimulation in transvenous pacing after mustard procedureCalogero Puntrello, Fabiana Lucà, Gaspare Rubino, et al.
Journal of Clinical Medicine|June 10, 2022
Reply to Kielb et al. Untapped Potential for Female Patients? Comment on "Lucà et al. Update on Management of Cardiovascular Diseases in Women. <i>J. Clin. Med.</i> 2022, <i>11</i>, 1176"Fabiana Lucà, Furio Colivicchi, Roberta Rossini, et al.
The American Journal of Cardiology|June 24, 2026
Semaglutide for the Silent Phenotype: A Translational Signal in Obesity-Driven HFpEFRoberto Ceravolo, Fabiana Lucà, Michele Massimo Gulizia, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 6, 2019
Emerging clinical setting of direct oral anticoagulants: atherothrombotic events preventionStefania A Di Fusco, Fabiana Lucà, Michele M Gulizia, et al.
World Journal of Cardiology|June 20, 2014
Unreliability of aortic size index to predict risk of aortic dissection in a patient with Turner syndromeJan Nijs, Sandro Gelsomino, Fabiana Lucà, et al.
Pageof 16